While their approach focused on clinical features, our proteomic analysis revealed that AD and DLB share highly correlated profiles (r = 0.59) and similar dysregulated pathways, such as microglial activation (TREM2, IL13, IL6R and IFNG) and neuronal processes. Here, TREM2 is linked to Alzheimer disease.